Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
Innovation (Cambridge (Mass.))
|
June 17, 2024
IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinoma
Chuanliang Cui, Juan Li, Yue Yang, et al.
BMC Cancer
|
May 20, 2022
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study
Li Zhou, Xiaowen Wu, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2023
Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial
Xuan Wang, Xiaowen Wu, Yue Yang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2023
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma
Yu Du, Jie Dai, Lili Mao, et al.
Frontiers in Surgery
|
January 20, 2022
Surgical Outcomes of Vaginal or Cervical Melanoma
Hui Tian, Xuan Wang, Bin Lian, et al.
Med (New York, N.Y.)
|
March 20, 2025
Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study
Xieqiao Yan, Juan Li, Huayan Xu, et al.
The Oncologist
|
March 27, 2023
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population
Li Zhou, Zhiting Shao, Yiqiang Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2021
Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma
Bixia Tang, Jiazhi Mo, Xieqiao Yan, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2021
Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort
Xue Bai, Michelle Kim, Gyulnara Kasumova, et al.
Urologic Oncology
|
February 21, 2024
Natural history of bone-only metastasis in renal cell carcinoma
Bixia Tang, Rong Duan, Zenan Fan, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
Innovation (Cambridge (Mass.))
|
June 17, 2024
IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinoma
Chuanliang Cui, Juan Li, Yue Yang, et al.
BMC Cancer
|
May 20, 2022
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study
Li Zhou, Xiaowen Wu, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2023
Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial
Xuan Wang, Xiaowen Wu, Yue Yang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2023
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma
Yu Du, Jie Dai, Lili Mao, et al.
Frontiers in Surgery
|
January 20, 2022
Surgical Outcomes of Vaginal or Cervical Melanoma
Hui Tian, Xuan Wang, Bin Lian, et al.
Med (New York, N.Y.)
|
March 20, 2025
Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study
Xieqiao Yan, Juan Li, Huayan Xu, et al.
The Oncologist
|
March 27, 2023
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population
Li Zhou, Zhiting Shao, Yiqiang Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2021
Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma
Bixia Tang, Jiazhi Mo, Xieqiao Yan, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2021
Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort
Xue Bai, Michelle Kim, Gyulnara Kasumova, et al.
Urologic Oncology
|
February 21, 2024
Natural history of bone-only metastasis in renal cell carcinoma
Bixia Tang, Rong Duan, Zenan Fan, et al.
Page
of 12